Perspective Therapeutics, Inc. — Director's Dealing 2022

Aug 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-08-05

Reporting Person: Streeter Jennifer (COO & VP of HR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-05	Common Stock	M	22500	$0.33	Acquired	27940	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-05	Stock Options (right to buy)	$0.33	M	22500	Disposed	2032-07-21	Common Stock (452500)	Direct

Footnotes

F1: 475,000 stock options were granted on 7/21/2022. 25% vested on 7/21/2022 and the remaining 75% will vest over the next three (3) years, commencing on 7/21/2022, until fully vested. The shares exercised on 8/5/2022 represent the shares that vested on 7/21/2022.